Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males

Clinical trial NCT00435695 · COMPLETED

Trial details

NCT number: NCT00435695
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Depressive Disorder and Anxiety Disorders

Start date: 2006-11-01
Primary completion: 2007-12-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.